AKTX Chart
- 52-Week Range: $1.05 - $1.87
- Market Capitalization: $67.06M
- Short Percentage: 0%
- Target Price: $5.00
- Shares Outstanding: 51.91M
- Next Earnings: Apr 19
Catalysts
CategoryCatalyst
Earnings
AKTX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Akari Therapeutics Reports Full Year 2021 Financial Results and Highlights Clinical ProgressGlobeNewsWire | May 16th
- Akari Therapeutics, Plc Announces $9.0 Million Registered Direct OfferingGlobeNewsWire | March 8th
- Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive OfficerGlobeNewsWire | March 2nd
- FDA Agrees to Use of New Higher-Yielding Manufacturing Process for Nomacopan in Pivotal Clinical StudiesGlobeNewsWire | January 19th
- Akari Therapeutics to Present at H.C. Wainwright BioConnect Virtual ConferenceGlobeNewsWire | January 4th
- Akari Therapeutics, Plc Announces $6.0 Million Registered Direct OfferingGlobeNewsWire | December 30th
- Akari Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Clinical ProgressGlobeNewsWire | December 3rd
Company Info
Website: https://www.akaritx.com
Address: 75/76 Wimpole Street, London, United Kingdom, W1G 9RT
Sector: Healthcare
Industry: Biotechnology
Full time employees: 9
Address: 75/76 Wimpole Street, London, United Kingdom, W1G 9RT
Sector: Healthcare
Industry: Biotechnology
Full time employees: 9
$AKTX nice gap
$AKTX we’re fucked tomorrow boys
$AKTX Buying more
$AKTX Bullish AF ??
$AKTX Buying again tomorrow.
$AKTX yes
keep going down
let's go
stop stalling
$AKTX we had no volume for days before the last big rip
$AKTX bull here. But I’m worried for tomorrow
$AKTX you wanna be a successful trader close your trades green
$AKTX is going to have a run next month